comparemela.com

Latest Breaking News On - Ruby engot en6 gog3031 nsgo trial - Page 1 : comparemela.com

Dostarlimab Plus Chemo Provides OS Benefit in Primary Advanced or Recurrent Endometrial Cancer

The addition of dostarlimab to carboplatin plus paclitaxel followed by dostarlimab monotherapy significantly improved overall survival compared with placebo plus chemotherapy followed by placebo in adult patients with primary advanced or recurrent endometrial cancer.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.